01
Jul

Sanofi CEO Chris Viehbacher is often pressed to answer why he doesn’t just buy Regeneron, a biotech outfit closely bonded with Big Pharma on several important development initiatives.

…read more

Source: Sanofi bumps stake in Regeneron to 22.5%

    

0 No comments